B-Secur appoints Mark Bogart as SVP of US healthcare

B-Secur has announced the appointment of Mark Bogart as Senior Vice President (SVP) of U.S. Healthcare.

Bogart will identify, develop and build long-term agreements with medical device and digital health companies and cultivate and manage customer relationships with existing partners.

The new SVP will also focus on delivering the company’s medical strategy for its newly launched HeartKey 2.0 technology.

Launched in April, HeartKey 2.0 has been shown to significantly reduce EKG signal noise, making EKG interpretation more accurate and efficient for clinicians.

The remote cardiac monitoring technology also offers a range of FDA-cleared health algorithms and actionable wellness insights.

Bogart said:

“Supported by a best-in-class engineering and product development team, B-Secur is at the forefront of signal conditioning and EKG rhythm analysis.

“The opportunity to engage and bring forward HeartKey 2.0 creates tremendous opportunities across the U.S. Medtech space and ultimately improves workflow, patient care and clinical outcomes.

“It’s a game changer for the industry and our physician providers.”

Bogart joins B-Secur from AliveCor where he was employed as an SVP of the U.S. Healthcare Division.

At AliveCor, he helped establish KardiaMobile 6L in the B2B markets, among other achievements.

B-Secur’s Chief Commercial Officer, Ben Carter, said:

“Since the launch of HeartKey 2.0 we have seen a strong growing demand across our key consumer and medical customers.

“Mark brings a wealth of leadership and business experience from across the medical industry.

“He has worked with some of the biggest medical device and platform companies in the world and has deep medical industry knowledge.

“I’m excited that Mark has agreed to join B-Secur and I look forward to working with him as we continue to grow our business, especially in the U.S.”